Advent International launches Cohance Lifesciences

Advent International yesterday launched Cohance Lifesciences, a new brand identity for its API and CDMO platform, which would comprise three portfolio companies in RA Chem Pharma, ZCL Chemicals and Avra Laboratories.

The setting up of Cohance Lifesciences is significant, as it would help in establishing a unified new brand identity for the API and CDMO platform, to better reflect its vision and operating philosophy. The new brand brings its API-focussed assets together under one platform. The platform is also forward integrated into pellets, formulations and clinical research to provide end-to-end offerings to its customers.

The company intends to add more assets in the future with the vision to become one of the top three merchant API and CDMO companies in India.

Speaking on the initiative, Pankaj Patwari, Managing Director, Advent, said, “……….Over the last two years, Advent International has acquired three unique, yet complementary businesses in the API/CDMO space, and has built a meaningful market position, demonstrating strong growth.”

Elaborating on the initiative and how Advent operates its companies with a common operating philosophy and values, Patwari said, “We have built a single leadership team for this API platform, which will help us to drive strong growth, synergies and operational efficiencies. Our business model has a strong focus on customer service, sustainability, efficient infrastructure and robust quality systems.”